Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Aerosol: SOP for Documenting Stability Testing Results – V 2.0

Posted on By

Aerosol: SOP for Documenting Stability Testing Results – V 2.0

SOP for Documenting Stability Testing Results

Department Aerosol
SOP No. SOP/Aerosol/107/2025
Supersedes SOP/Aerosol/107/2022
Page No. Page 1 of Y
Issue Date 06/02/2025
Effective Date 16/02/2025
Review Date 06/02/2028

1. Purpose

This Standard Operating Procedure (SOP) outlines the process for documenting the results of stability testing of aerosol products. The purpose is to ensure that stability study results are accurately captured, maintained, and reported in a consistent and compliant manner. Proper documentation supports the validation of product stability and shelf life, ensuring regulatory compliance and product integrity throughout its lifecycle.

2. Scope

This SOP applies to all stability testing conducted for aerosol products at [Company Name]. It covers the documentation of test results from long-term, accelerated, and intermediate stability studies, including data capture, analysis, and reporting of results for regulatory and internal purposes.

3. Responsibilities

  • Stability Testing Team: Responsible for performing stability tests, recording the results, and ensuring the accuracy of the data captured during the stability study.
  • Quality Assurance (QA) Team: Responsible for overseeing the documentation process, reviewing test results for completeness and accuracy, and ensuring compliance with GMP and regulatory requirements.
  • Regulatory Affairs Team: Ensures that the stability testing and documentation meet the requirements of regulatory agencies, including the FDA, ICH, and other relevant authorities.
  • Production Team: Provides samples for testing and ensures
that they are correctly labeled and documented prior to stability testing.

4. Accountability

The Manufacturing Manager is accountable for ensuring that the stability testing results are documented according to this SOP. The overall compliance with this SOP is overseen by the Quality Assurance (QA) Manager.

5. Procedure

5.1. Documentation of Stability Test Data

  1. During the stability study, all observations, measurements, and test results should be recorded accurately. This includes:
    • Temperature and humidity levels in the stability chambers
    • Product performance (e.g., appearance, functionality, spray rate, valve operation)
    • Chemical and physical tests (e.g., active ingredient concentration, viscosity, pH)
  2. Data should be recorded in the Stability Testing Results Log (Annexure-1) in a consistent and legible manner, with all fields filled in completely. Any deviations or anomalies in the data should be clearly marked and documented with an explanation in the Deviation Log (Annexure-2).
  3. All results should be dated and signed by the responsible personnel. If data entry is done electronically, it must be validated and backed up regularly to ensure the integrity of the records.

5.2. Handling of Deviations and Anomalies

  1. If any deviations from the planned stability testing conditions are observed, they should be recorded in the Deviation Log (Annexure-2). The following steps should be taken:
    • Investigate the cause of the deviation (e.g., equipment malfunction, incorrect product handling, environmental control failure).
    • Assess whether the deviation could affect the integrity of the stability results.
    • Implement corrective actions as necessary, and document the actions taken in the Corrective Action Log (Annexure-3).
  2. The QA team should review any deviations to ensure appropriate actions are taken and that the integrity of the stability study is maintained.

5.3. Analysis and Review of Results

  1. After the stability study is completed, the results should be reviewed by the QA team. The analysis should include:
    • Comparing the results against predefined acceptance criteria for stability (e.g., appearance, chemical composition, performance).
    • Identifying any significant changes in the product that may indicate instability.
    • Assessing the data in relation to the intended shelf life and the stability conditions under which the product was tested.
  2. If the results meet the specified stability criteria, the product can be approved for further processing or release. If there are deviations, the product may need further testing, adjustments, or re-evaluation.

5.4. Reporting of Stability Testing Results

  1. Upon completion of the stability study and analysis of results, a formal report should be prepared, which includes:
    • The objectives and scope of the stability study
    • Test conditions and results for each time point and sample
    • Any deviations or anomalies observed during the study
    • Conclusions regarding product stability and shelf life
  2. The stability report should be reviewed by the QA team and other relevant departments (e.g., Regulatory Affairs, Production). Once approved, it should be stored in the company’s records for future reference and regulatory compliance.
  3. The report should also include recommendations for the product’s shelf life, storage conditions, and any additional stability testing that may be needed.

5.5. Documentation Storage and Retention

  1. All stability testing results, including raw data, test logs, deviation records, and final reports, should be stored securely in both electronic and/or physical formats. These records should be accessible for internal audits and external regulatory inspections.
  2. Stability testing records should be retained for a minimum of 3 years or as required by regulatory guidelines, whichever is longer.

6. Abbreviations

  • GMP: Good Manufacturing Practice
  • QA: Quality Assurance
  • SOP: Standard Operating Procedure
  • RH: Relative Humidity
  • ACT: Actuator
  • VAL: Valve
  • CAPA: Corrective and Preventive Action

7. Documents

  1. Stability Testing Results Log (Annexure-1)
  2. Deviation Log (Annexure-2)
  3. Corrective Action Log (Annexure-3)
  4. Stability Testing Report (Annexure-4)

8. References

This SOP is based on the following regulatory guidelines and industry standards:

  • Good Manufacturing Practice (GMP) Guidelines
  • FDA Code of Federal Regulations (CFR) Title 21, Part 211
  • International Council for Harmonisation (ICH) Guidelines

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Stability Testing Results Log

Batch Number Test Date Test Results Operator Name Remarks
Batch-001 10/02/2025 Pass Rajesh Patel No deviations

Annexure-2: Deviation Log

Deviation ID Deviation Description Corrective Action Responsible Person Status
DEV-12345 Temperature deviation detected Re-calibrated equipment and re-tested Rajesh Patel Completed

Annexure-3: Corrective Action Log

Action ID Action Description Assigned To Completion Date Remarks
ACT-12345 Replaced faulty actuator Rajesh Patel 10/02/2025 Action completed successfully

Annexure-4: Stability Testing Report

Batch Number Test Date Results Summary Operator Name Final Conclusion
Batch-001 10/02/2025 Passed stability tests Rajesh Patel Approved for release

12. Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By Page No. Ref. Point No. Details of Revision
01/01/2024 V 1.0 Initial Release First Issue Anjali Sharma Page 1 [Ref Point] First Release
01/01/2025 V 2.0 Updated documentation process To comply with updated GMP regulations Anjali Sharma Page 1 [Ref Point] Updated procedures
See also  Aerosol: SOP for Preparing Stability Study Reports for Aerosols - V 2.0
Aerosols V 2.0 Tags:Aerosol Batch Production, Aerosol Can Design, Aerosol Cold Filling, Aerosol Documentation Standards, Aerosol Emissions Control, Aerosol Environmental Regulations, Aerosol equipment calibration, Aerosol Filling Process, Aerosol Fire Safety Measures, Aerosol Formulation, Aerosol Good Manufacturing Practice (GMP), Aerosol Hazardous Materials Handling, Aerosol Incident Reporting, Aerosol Leak Testing, Aerosol Maintenance Schedules, Aerosol Personal Protective Equipment (PPE), Aerosol Pressure Filling, Aerosol Product Labeling, Aerosol Product Testing, Aerosol Propellant Selection, Aerosol quality control, Aerosol Regulatory Compliance, Aerosol Risk Assessment, Aerosol Safety Protocols, Aerosol Standard Operating Procedures (SOPs), Aerosol Storage Requirements, Aerosol Training Programs, Aerosol Valve Crimping, Aerosol Ventilation Systems, Aerosol Waste Disposal

Post navigation

Previous Post: SOP for Corrective and Preventive Action (CAPA) in Storage Issues – V 2.0
Next Post: BA-BE Studies: SOP for Review of Subject Recruitment Feasibility – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version